Skip to content

Assessment of Right Ventricular 2d-strain in Acute Respiratory Distress Syndrome

ARDStrain : Assessment of Right Ventricular 2d-strain in Acute Respiratory Distress Syndrome

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02638844
Acronym
ARDStrain
Enrollment
49
Registered
2015-12-23
Start date
2015-12-31
Completion date
2017-08-31
Last updated
2018-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Keywords

echocardiography

Brief summary

Assessment of right ventricular (RV) function in patients with acute respiratory syndrome (ARDS) is warranted because RV failure is frequent and associated with worse outcome. Transthoracic echocardiography is the cornerstone of RV assessment but it remains challenging. Quantification of RV deformation by speckle-tracking imaging echocardiography (STE) is a widely available and reproducible technique that readily provides an integrated analysis of all segments of the RV. This study aims to investigate the accuracy of STE-derived strain parameters in assessing RV function during ARDS.

Interventions

None listed

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients with moderate or severe ARDS (Berlin definition) * receiving mechanical ventilation (\>48h estimated length) * Transthoracic echocardiography performed during the first 36h after ICU admission

Exclusion criteria

* pregnancy * protected or deprived of Liberty major * chronic respiratory disease * history of clinical right heart failure * chronic heart failure with LVEF \< 35% * severe valvular heart disease * under 18 or protected-adults

Design outcomes

Primary

MeasureTime frame
Measure of longitudinal peak systolic strainup to 36 hours after Intensive Care Unit admission

Secondary

MeasureTime frame
Measure of PaO2/FiO2 ratioup to 36 hours after Intensive Care Unit admission
Ventilator-free days28 days
Mortality28 days

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026